Mifeprex FDA Approvals Remain Unchanged, April 21, 2023 NEW YORK, April 21, 2023 /PRNewswire/ — We at Danco are gratified the Supreme Court has granted a stay, which keeps the approval of Mifeprex intact without any changes. This stay is an important step in maintaining access to…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.